Module 1: Pharmacodyamics Flashcards

1
Q

Define pharmacodynamics

A

What a drug does to the body (effects, mechanism of action)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Define pharmacokinetics

A

How the body handles the drug (absorption, distribution, metabolism, excretion)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is an example of endogenous ligands?

A

Hormones or neurotransmitters

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Drugs are administered to achieve which two affects?

A

A beneficial response or a selective toxic effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are four common types of receptors?

A

Regulatory proteins, transporters, enzymes, structural proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the four common signalling mechanisms of regulatory proteins?

A

Ligand gated ion channels as receptors

G-protein coupled receptors

Intracellular receptors

Regulated Transmembrane Enzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Briefly describe regulatory proteins

A

Proteins that mediate the actions of endogenous chemical signals.

Generally mediate transmembrane signalling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the location of ligand gated ion channels?

A

Channels span across the cell membrane, with portions protruding out each side

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What do ligand gated ion channels transport?

A

Sodium, chloride, and other ions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How does the ligand-gated ion channel open?

A

An endogenous ligand or drug binds to the receptor on the outside, causing a conformational change in the protein, opening it and allowing ions to flow through

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is an example of a ligand gated ion channel?

A

Nicotinic receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Where are G-protein coupled receptors located?

A

They span the outside to inside of the cell membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How do G-protein coupled receptors activate?

A

A drug binds to the receptor on the outside of the cell membrane, a conformational change of the receptor protein occurs and activated the G-protein. The G-protein activates a number of second messenger systems that amplify the signal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

T/F - G-protein coupled receptors are a faster process than ligand-gated ion channels

A

False! G-protein coupled receptors are slower due to the activation of second messengers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What activates G-protein coupled receptors?

A

Drugs, hormones, neurotransmitters, other signalling molecules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What kinds of molecules activate intracellular receptors?

A

Lipid-soluble ones (including lipid soluble drugs), such as steroid hormones (cortisol) and thyroid hormones (Thyroxine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What affect does activating an intracellular receptor have on the cell?

A

Gene expression is modified and therefore subsequent protein synthesis (whether an increase or decrease)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Why is the intracellular receptor process the slowest?

A

New proteins have to be synthesized and it takes time for those proteins to accumulate to produce an observed effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe where transmembrane enzymes are located

A

Located on the outside of the cell, but linked to an enzyme inside the cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How are regulated transmembrane enzymes activated?

A

When a drug binds to the extracellular receptor, the change in the receptor-drug complex allows for the activation of an enzyme that activates biochemical reactions to produce a biological effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Describe: non-competitive antagonist

A

Binds irreversibly to a receptor but does not activate it. Causes a conformational change of the receptor, inhibiting an agonist from binding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Describe: Competitive antagonist

A

Bind to the same spot on the receptor as the agonist, but does not produce a response. Does not allow for agonists to bind

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Protein kinases are which type of enzyme?

A

Regulated transmembrane enzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Describe: Partial agonist

A

Bind to the receptor and activate it, but produce a weaker response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

T/F - All drugs are mediated by receptors

A

False. Some drugs interact non-specifically with the biological system.

Ex., antacids use an acid-base neutralization reaction
Ex., Some chemotherapy drugs chemically disrupt cancer cell function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Describe: Agonist

A

Agonist bind to the receptors and activate it

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Describe: Allosteric activator

A

Binds to a different area of the receptor than the agonist, but makes it easier for the receptor to be activated. Increases the ability of an agonist to activate a receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is the graded dose response relationship?

A

Describes a drug effect which increases in proportion to increasing the drug dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Why does the inhibition from a non-competitive antagonist more permanent than that of a competitive antagonist

A

Because non-competitive antagonists cause a conformational change instead of just fighting for the receptor site, increasing the concentration of agonist does not overcome the inhibition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is the ED50?

A

The dose of a drug that will result in 50% of the maximal effect, or the dose of a drug that is effective in 50% of a population

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the receptor threshold?

A

The minimum number of receptors that need to be activated to observe a measurable response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

T/F - The dose is proportional to the effect only after the receptor threshold has been reached

A

True!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Describe the maximal response

A

The response where further increases in dose will no longer correspond to increases in therapeutic effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Will an agonist, partial agonist, or allosteric activator plus an agonist have the greatest maximal effect?

A

An allosteric activator plus an agonist, followed by the agonist, followed by the partial agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Define efficacy

A

The maximum pharmacological response that can be produced by a specific drug in that biological system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Define potency

A

The dose or concentration of a drug that is required to produce a response of a certain magnitude - usually 50% of the maximal response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Drug A produces a response at 40mg, Drug B produces the same response at 20mg. Is drug B more efficacious or more potent?

A

Drug B is more potent, as it is producing the same response, but at a lower dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Drug A can treat pain patients say is a 10/10. Drug B can treat pain that is described as a 3/10. Is Drug A more efficacious or potent?

A

Drug A is more efficacious. It can produce a greater maximum effect.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

T/F - Clinically, efficacy is more important than potency

A

True! Maximal effectiveness of a drug is generally what determines which drug is chosen to treat a condition. The potency doesn’t matter as much, as doses can be adjusted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Describe the therapeutic range

A

The range of drug concentration in the plasma that is above the minimum concentration to produce a response, but below toxic concentrations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What are the four processes of pharmacokinetics

A

Absorption
Distribution
Metabolism
Excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Describe absorption

A

The movement of a drug from the site of administration into the blood

29
Q

Describe distribution

A

The movement of a drug from the blood to the site of action and other tissues

29
Q

Describe metabolism (biotransformation)

A

The conversion of a drug into a different compounds, usually a more water-soluble one

29
Q

What is bioavailability?

A

The percentage of an administered dose that reaches the blood in active form

29
Q

The unionized form of a drug is ___ soluble

A

Lipid soluble

29
Q

Describe excretion

A

The removal of a drug and its products from the body

29
Q

What route of administration guarantees 100% bioavailability?

A

Intravenous administration

29
Q

What is a weak base?

A

A neutral molecule that can combine with protons to become positively charged

29
Q

What are some of the key components of the absorption?

A

Breakdown of excipients (medium for the drug to enter the body), dissolution in GI fluids, crossing of biological membranes

29
Q

In an acidic environment, will the ionized or unionized form of a weak base predominate?

A

The ionized - as there are plenty of protons available

29
Q

What is a weak acid?

A

A drug that is a neutral molecule that can dissociate into a negatively charged molecule and a proton

30
Q

The ionized form of a drug is ___ soluble

A

Water soluble

31
Q

In an acidic environment, will the ionized or unionized form of a weak acid predominate?

A

The unionized

31
Q

In a basic environment, will the ionized or unionized form of a weak base predominate?

32
Q

In a basic environment, will the ionized or unionized form of a weak acid predominate?

33
Q

Under acidic conditions, which drug (acid or base) is lipid soluble?

34
Q

Under basic conditions, which drug (acid or base) is lipid soluble?

35
Q

Where are most dugs absorbed? Why?

A

The small intestine - due to its permeability, large surface area, and high blood flow

36
Q

If the concentration of a drug in the blood drops below the concentration at any of its distribution sites - what happens?

A

The drug will move from the site back into the blood to maintain an equilibrium

37
Q

T/F When a drug is bound to a protein it cannot act and will be excreted

A

True! Only free drugs are able to act - as drugs bound to proteins cannot reach their site of action

38
Q

What is the organ where most biotransformation reactions occur?

39
Q

What is a phase 1 reaction

A

The addition or unmasking of a functional group so phase 2 reactions can proceed

40
Q

What enzyme performs the majority of biotransformation reactions?

A

Cytochrome P450 (CYPs) - specifically CYP3A4

41
Q

What is the issue with most drugs using the same enzyme to metabolize its products?

A

Drugs can compete for the attention of CYP3A4

42
Q

What are the 4 chemical reactions that can be used for biotransformation

A

Oxidative reactions using CYPs, oxidative reactions of amines, dehydrogenation of alcohol to aldehydes, hydrolysis of esters and amides

43
Q

What are phase 2 reactions?

A

The addition of a large water-soluble moiety to the product from phase 1 - making it water-soluble so the kidney can excrete it

44
Q

What is the first pass effect?

A

The biotransformation and inactivation of a drug during absorption from the intestine. The biotransformation of a drug as its absorbed due to the intestine’s biotransformation enzymes

45
Q

What is a consequence of the first pass effect?

A

A reduction in the amount of active drug reaching the blood and therefore site of action

46
Q

What are 4 factors that can affect biotransformation

A

Other drugs being taken competing for the same enzyme
Genetic factors (slow vs fast metabolizers)
Age (decrease in biotranformation enzymes at birth and in ppl >60)
Disease states (diseases that affect the liver)

47
Q

If someone has kidney disease - how will this affect drug elimination?

A

Glomerular filtration will be decreased and therefore excretion will be decreased

48
Q

If someone has basic urine, what drugs (acidic or basic) will be excreted more?

49
Q

What are the three processes that occur in renal excretion?

A

Glomerular filtration, passive tubular reabsorption, active tubular secretion

50
Q

What is first order kinetics?

A

A constant fraction of the drug is eliminated over a set period of time (if there is [20mg] of drug in the blood and the body eliminates 50% over 4 hours - there will be [10mg] at the end of the 4 hours. After another 4 hours, [5mg] will be left

51
Q

What is zero-order kinetics?

A

A constant amount of the drug is eliminated in set period of time because the enzymes responsible are saturated. (ex., no matter how much alcohol is consumed - only 10-13mL will be eliminated per hour)

52
Q

What is the plateau principle?

A

After about 5 half-lives, the rate of drug input is equal to drug output. The plasma concentration of the drug has reached a steady state

53
Q

What is the therapeutic index?

A

An index telling you how safe a drug is.

54
Q

How do you calculate the therapeutic index?

A

TD50 (toxic dose to 50% of the population) / ED50 (effective dose to 50% of the population)

55
Q

Can you name the 8 common adverse drug reactions? (I def can’t)

A

Extension of therapeutic effect
Effects in non-target areas
Unrelated to main drug action
Drug idiosyncrasy
Allergic reactions
Adverse biotransformation reactions
Tolerance, withdrawal and addiction
Teratogenesis (Birth defects)

56
Q

Describe the adverse effect, give an example & solution: Extension of therapeutic effect

A

Occurs when too much of the drug is in the blood (drug overdose)
In order to stop this adverse reaction, you can reduce the dose of the drug
Too much of an anticoagulant will cause bleeding

57
Q

Describe the adverse effect, give an example & solution: Effects in non-target tissues

A

When receptors for the drug exist in more areas than just the target tissues - effects will occur in these other areas
Ex., morphine produces analgesic effects by acting on opioid receptors in the CNS, but also act on opioid receptors in the GI tract causing constipation
Solution: Decrease dose

57
Q

Describe the adverse effect: Unrelated to main drug action

A

Effects that are unexpected and unrelated to the intended pharmacological action of the drug. Drug acts on other receptors other than the ones involved in therapeutic effect

Similar to effects in non-target tissues - but different in the drug is acting on different types of receptors

57
Q

Describe the adverse effect: Drug idiosyncrasy

A

A genetic condition causing an unusual response to a drug

57
Q

Describe the adverse effect: Allergic reactions

A

Adverse effect mediated by the immune system. An antigen-antibody combination provokes an unwanted reaction

57
Q

Describe the adverse effect, give an example & solution: Adverse biotransformation reactions

A

A drug is converted into a chemically reactive metabolite that can cause damage.
Ex., overdose of acetaminophen leads to production of chemically reactive metabolites that cause liver injury
Solution: Take only recommended dose

57
Q

Describe the adverse effect & solution: Teratogenesis

A

Refers to drug-induced defects in the developing fetus
Solution: avoid drugs with these effects during pregnancy

57
Q

Describe an antagonistic drug-drug interaction

A

One drug reduces the pharmacological effect of another drug by competing for the same receptor to produce a different response

57
Q

Who are at greater risks for adverse reactions?

A

Newborns and those over 60 years of age
Those with multiple diseases
Genetics (particularly slow metabolizers)

57
Q

Give some reasons why drug toxicity can be difficult to predict

A

Rare adverse effects
Toxic reactions only occur after prolonged use
Toxic effect is not detectable in animals
Adverse effect is unique to only a particular period (ex., when pregnant)

57
Q

Describe an additive drug-drug interaction

A

The combined pharmacological effect of the two drugs is the sum of the individual effects (1+1=2). Occurs when the drugs bind the same receptor

58
Q

Describe an altered physiology drug-drug interaction

A

One drug may alter the normal physiology of the body so that the response of another drug is altered

58
Q

What are the five types of drug-drug interactions?

A

Additive
Synergistic
Potentiation
Antagonism
Altered physiology

58
Q

Describe a potentiation drug-drug interaction

A

The pharmacological effect of one drug is increased by a second drug

58
Q

Describe a synergistic drug-drug interaction

A

The combined pharmacological effect of two drugs is greater than the sum of the individual effects (1+1 =3). Occurs when the drugs bind different receptors, but have the same overall effect

58
Q

What are some risk factors for drug-drug interactions?

A

Age - decreased liver and kidney function causing drugs to stay around longer
Polypharmacy (taking multiple drugs)
Genetic factors (slow metabolizers)
Drug properties (low therapeutic index, extensive blood protein binding)

59
Q

What is preclinical testing?

A

Testing of compounds to determine their safety and potential efficacy

60
Q

What does a phase 1 clinical trial look for

A

Safety and tolerability in a few healthy individuals

60
Q

What does a phase 2 clinical trial look for?

A

Effectiveness, safety and pharmacokinetics in those with the disease its meant to treat. Divided into control groups and treatment groups

61
Q

What does a phase 3 clinical trial look for?

A

Effectiveness and safety in a large amount of people with the disease

62
Q

What does a phase 4 clinical trial look for?

A

Long term safety - after marketing and distribution to the public

62
Q

What does an acute toxicity study look into?

A

Looks into determining the toxicity of a drug after a single administration over a short period of time (a few days) with several different doses

63
Q

What does a sub-chronic toxicity study look into?

A

Toxicity over a longer period of time (few weeks to 3 months) with about 3 different doses

63
Q

What does a chronic toxicity study look into?

A

Toxicity over a longer period of time (6 months - 2 years) with about 3 different doses